North Run Capital’s Imperva, Inc. IMPV Stock Holding History

North Run Capital’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-330,000	Closed	-$15.3M	–	25
2018 Q3	$15.3M	Buy	330,000 +58,000	+21%	+$2.81M	7.62%	3
2018 Q2	$13.1M	Sell	272,000 -81,000	-23%	-$3.87M	7.07%	4
2018 Q1	$15.3M	Sell	353,000 -276,659	-44%	-$12.4M	8.46%	4
2017 Q4	$25M	Buy	629,659 +37,058	+6%	+$1.54M	15.27%	2
2017 Q3	$25.7M	Buy	592,601 +82,601	+16%	+$3.77M	12.09%	1
2017 Q2	$24.4M	Sell	510,000 -240,000	-32%	-$11.2M	13%	3
2017 Q1	$30.8M	Buy	750,000 +681,772	+999%	+$28.5M	10.94%	4
2016 Q4	$2.62M	Buy	+68,228	New	+$2.77M	0.8%	16

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

North Run Capital's IMPV Position: Q4 2018 in Review

North Run Capital sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 330,000 shares — an estimated $15.3M sold.

North Run Capital first reported a position in IMPV in Q4 2016 and held it in 8 quarters. The position peaked at $30.8M in Q1 2017. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

North Run Capital reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
North Run Capital sold 330,000 Imperva, Inc. shares in Q4 2018, an estimated $15.3M.
North Run Capital first reported a position in Imperva, Inc. in Q4 2016 and held it in 8 quarters.
North Run Capital's Imperva, Inc. position peaked at $30.8M in Q1 2017.
162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on North Run Capital's 13F filing for Q4 2018, filed 14 Feb 2019.